The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor blockade

Spiroperidol, which blocks dopamine (DA) receptors, attenuated self-stimulation of the nucleus accumbens, septal area, hippocampus, anterior hypothalamus and ventral tegmental area. Dopamine is thus involved in self-stimulation of many sites (in addition to the lateral hypothalamus). The attenuation was not a simple motor impairment of the speed of bar-pressing in that the nucleus accumbens and septal self-stimulation rates were lower than those in treated animals self-stimulating at other sites (Experiment 1). Feeding was partly attenuated, and drinking was much less attenuated by the spiroperidol. Since the rats bar-pressed for brain-stimulation reward, chewed pellets to eat, and licked a tube to drink, dopamine-receptor blockade may attenuate complex motor responses most. Alternatively, the blockade could affect brain-stimulation reward more than the controls of eating, and these latter more than the controls of drinking (Experiment 2). In Experiment 3, feeding and drinking were equally and severely attenuated when rats had to bar-press to obtain food or water. The attenuation was to a level similar to that found for self-stimulation. These experiments suggest that dopamine receptor blockade impairs eating, drinking and self-stimulation by interfering with complex motor responses.

[1]  U. Ungerstedt Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[2]  Anthony G. Phillips,et al.  Dopaminergic and Noradrenergic Substrates of Positive Reinforcement: Differential Effects of d- and l-Amphetamine , 1973, Science.

[3]  U. Ungerstedt Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.

[4]  P. Stark,et al.  Sensitivity and specificity of positive reinforcing areas to neurosedatives, antidepressants and stimulants. , 1969, Journal of Pharmacology and Experimental Therapeutics.

[5]  J. Harvey,et al.  LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle. , 1972, Physiology & behavior.

[6]  Brain stimulation reward „Thresholds” self-determined in rat , 1960, Psychopharmacologia.

[7]  B. Costall,et al.  Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. , 1972, Neuropharmacology.

[8]  T. Crow,et al.  A map of the rat mesencephalon for electrical self-stimulation. , 1972, Brain research.

[9]  U. Ungerstedt,et al.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.

[10]  O. Hornykiewicz Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.

[11]  E. Rolls,et al.  The neural basis of brain-stimulation reward. , 1975, Progress in neurobiology.

[12]  T. Hökfelt,et al.  Morphological and Functional Aspects of Central Monoamine Neurons , 1970 .

[13]  E. Rolls,et al.  Neural basis of stimulus-bound locomotor activity in the rat. , 1972, Journal of comparative and physiological psychology.

[14]  C. Niemegeers,et al.  Intracranial self-stimulation in rats as a function of various stimulus parameters , 2004, Psychopharmacologia.

[15]  C. Niemegeers,et al.  Intracranial self-stimulation in rats as a function of various stimulus parameters , 1974, Psychopharmacologia.

[16]  E. Rolls,et al.  Noradrenaline, dopamine, and brain-stimulation reward. , 1974, Pharmacology, biochemistry, and behavior.

[17]  C. G. Heller,et al.  Fine Structure of Muscle Cells of the Human Testicular Capsule: Basis of Testicular Contractions , 1973, Science.